Varices, Esophageal Completed Phase 1 / 2 Trials for Octreotide (DB00104)

Also known as: Oesophageal Varices / Esophageal Varices / Varices oesophageal / Esophageal varices without bleeding / Varices esophageal / Esophageal varices (disorder) / Oesophageal varices NOS / Esophageal varices with bleeding / Oesophageal varices haemorrhage / Oesophageal varices ruptured / Esophageal varices ruptured / Oesophageal varices with bleeding / Bleeding oesophageal varices / Esophageal varices hemorrhage / Bleeding esophageal varices / Bleeding esophageal varices (disorder)

IndicationStatusPhase
DBCOND0046998 (Varices, Esophageal)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01188733Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With CirrhosisPrevention